Traditionally, arthritis is considered to be a “surface problem” because it causes progressive degeneration of the surface layer of cartilage that protects joints. But new research* and studies have revealed that arthritis is a systemic degenerative process that likely follows this path:

Bone pathologies like bone marrow lesions and osteonecrosis may develop as a result of acute or chronic injury to a joint. Swelling and reduced blood flow reaching the bone may cause progressive damage, severe pain and disability.

These pathologic conditions tend to progress rapidly for the majority of patients who develop bone marrow lesions and osteonecrosis. Over time, cartilage degradation and loss occurs.

Left untreated, bone pathologies like bone marrow lesions and osteonecrosis leave patients with limited options, such as undergoing invasive joint replacement surgery to help reduce pain and restore joint mobility.

Arthritis involves degeneration of surface cartilage along with degeneration of the underlying bone and connective tissue. Therefore, methods that only treat the surface loss of cartilage will not likely stop the progression of disease as the underlying bone continues to weaken and degenerate. Patients will likely continue to suffer from severe pain and declining movement and mobility.

However, a treatment method like iO-Core™ that addresses both the surface loss of cartilage and underlying bone damage may help patients reduce pain, regain mobility and may prevent further progression without the need to undergo a potential invasive surgery.